Management and prevention of postoperative Crohn's disease

Inflammatory Bowel Diseases

Volumn 15, Issue 10, 2009, Pages 1583-1590

  Regueiro, Miguel ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Crohn's disease; Infliximab; Postoperative; Surgery

Indexed keywords

AZATHIOPRINE; BUDESONIDE; HYDROCORTISONE; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; NITROIMIDAZOLE; ORNIDAZOLE; PLACEBO; PREDNISONE; SALAZOSULFAPYRIDINE;

CIGARETTE SMOKING; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CROHN DISEASE; EARLY INTERVENTION; GASTROSCOPY; HUMAN; INTESTINE SURGERY; LOW DRUG DOSE; MAINTENANCE THERAPY; MONOTHERAPY; PATIENT MONITORING; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RELAPSE; REMISSION; REOPERATION; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SINGLE DRUG DOSE; SMOKING CESSATION; SURGICAL RISK; TREATMENT DURATION; TREATMENT RESPONSE;

CROHN DISEASE; HUMANS; POSTOPERATIVE COMPLICATIONS; RECURRENCE;

EID: 69949153607     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20909     Document Type: Review

References (45)

1. Cones J, Nion-Larmurier I, Beaugerie L, et al. Impact of increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut. 2005:54:237-241. (Pubitemid 40139240)
2. Bennell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg. 2000:231:38-45. (Pubitemid 30043937)
3. Sachar DB. The problem of postoperative recurrence of Crohn's disease. Med Clin North Am. 1990;74:183-188.
4. Olaison G, Smedh K, Sjodahl R. Natural course of Crohn's disease after ileocolic resection: endoscopically visualized ileal ulcers preceding symptoms. Gut. 1992;33:331-335.
5. Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology. 1990;99:956-983. (Pubitemid 20338451)
6. D'Haens G, Geboes K, Peeters M, et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology. 1998;114:262-267. (Pubitemid 28093532)
7. Rutgeerts P, Goboes K, Peeters M, et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet. 199128;338:771-774.
8. Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology. 1990 Oct; 99:956-963. (Pubitemid 20338451)
9. Michelassi F, Balestracci T, Chappel R, et al. Primary and recurrent Crohn's disease: experience with 1379 patients. Ann Surg. 1991;214:230-240.
10. Sutherland LR, Ramcharan S, Bryant H, et al. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology. 1990;98:1123-1128. (Pubitemid 20143093)
11. Cosnes J, Carbonnel F, Beaugerie L, et al. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology. 1996;110:424-431. (Pubitemid 26043875)
12. Mekhjian HS, Switz DM, Watts HD, et al. National Cooperative Crohn's Disease Study: factors determining recurrence of Crohn's disease after surgery. Gastroenterology. 1979;77:907-913. (Pubitemid 9242052)
13. Caprilli R, Corrao G, Taddei G, et al. Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Dis Colon rectum. 1996;39:335-341.
14. Greenstein AJ, Lachman P, Sachar DB, et al. Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut. 1988;29:588-592. (Pubitemid 18145437)
15. Lautenbach E, Berlin JA, Lichtenstein GR. Risk factors for early postoperative recurrence of Crohn's disease. Gastroenterology. 1998;115:259-267. (Pubitemid 28363417)
16. Avidan B, Sakhnini E, Lahat A, et al. Risk factors regarding the need for a second operation in patients with Crohn's disease. Digestion. 2005;72:563-571.
17. Regueiro M, Schraut W, Kip K, et al. The one year postoperative Crohn's Disease Activity Index (CDAI) correlates poorly with endoscopic recurrence and remission. Gastroenterology. A2009 (in press).
18. Regueiro M, Schraut W, Baidoo L, et al. Two year postoperative follow up of patients enrolled in the randomized controlled trial of infliximab for prevention of recurrent Crohn's disease. Gastroenterology. A2009 (in press).
19. Ng SC, Kamm MA. Management of postoperative Crohn's disease. Am J Gastroenterol. 2008;103:1029-1035.
20. Wenckert A, Kristensen M, Eklund AE, et al. The long-term prophylactic effect of salazosulphapyridine (Salazopyrin) in primarily resected patients with Crohn's disease. A controlled double-blind trial. Scand J Gastroenterol. 1978;13:161-167. (Pubitemid 8278453)
21. Sutherland LR, Martin F, Bailey RJ, et al. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group. Gastroenterology. 1997;112:1069-1077.
22. Summers RW, Switz DM, Sessions JT Jr, et al. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology. 1979;77(4 Pt 2):847-869. (Pubitemid 9242048)
23. Ewe K, Herfarth C, Malchow H, et al. Postoperative recurrence of Crohn's disease in relation to radicality of operation and sulfasalazine prophylaxis: a multicenter trial. Digestion. 1989;42:224-232. (Pubitemid 19212478)
24. McLeod RS, Wolff BG, Steinhart AH, et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology. 1995;109:404-413.
25. Lochs H, Mayer M, Fleig W, et al. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI. Gastroenterology. 2000;118:264-273. (Pubitemid 30067499)
26. Brignola C, Cottone M, Pera A, et al. Italian Cooperative Study Group. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Gastroenterology. 1995;108:345-349.
27. Florent C, Cortot A, Quandale P, et al. Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). Eur J Gastroenterol Hepatol. 1996;8:229-233.
28. Caprilli R, Andreoli A, Capurso L, et al. Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Aliment Pharmacol Ther. 1994;8:35-43.
29. Caprilli R, Cottone M, Tonelli F, et al. Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial. Aliment Pharmacol Ther. 2003;17:517-523. (Pubitemid 36384811)
30. Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology. 1995;108:1617-1621.
31. Rutgeerts P, Van Assche G, Vermeire S, et al. Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2005;128:856-861. (Pubitemid 40523538)
32. Hellers G, Cortot A, Jewell D, et al. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology. 1999;116:294-300.
33. Ewe K, Böttger T, Buhr HJ, et al. Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group. Eur J Gastroenterol Hepatol. 1999;11:277-282. (Pubitemid 29286681)
34. Ardizzone S, Maconi G, Sampietro GM, et al. Azathioprine and mesalamine for the prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology. 2005;127:730-740.
35. Hanauer SB, Korelitz BI, Rutgeerts P, et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology. 2004;127:723-729. (Pubitemid 39208405)
36. D'Haens GR, Vermeire S, Van Assche G, et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial. Gastroenterology. 2008;135:1123-1129.
37. Sorrentino D, Terrosu G, Avellini C, et al. Prevention of postoperative recurrence of Crohn's disease by infliximab. Eur J Gastroenterol Hepatol. 2006;18:457-459.
38. Sorrentino D, Terrosu G, Avellini C, et al. Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease. Arch Intern Med. 2007;167:1804-1807. (Pubitemid 47403070)
39. Regueiro M, Schraut W, Baidoo L, et al. Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenterology. 2009;136:441-450.
40. Terdiman JP. Prevention of postoperative recurrence in Crohn's disease. Clin Gastroenterol Hepatol. 2008;6:616-620.
41. Renna S, Cammà C, Modesto I, et al. Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn's disease. Gastroenterology. 2008;135:1500-1509.
42. Yamamoto T, Umegae S, Matsumoto K. Impacts of infliximab on early endoscopic recurrence after resection for Crohn's disease: a prospective pilot study. Inflamm Bowel Dis. 2009 (in press).
43. Regueiro, M, Siemanowski B, Kip KE, Plevy, S. Infliximab dose intensification in Crohn's disease. Inflamm Bowel Dis. 2007;13:1093-1099. (Pubitemid 47402592)
44. Shergill AK, Terdiman JP. Controversies in the treatment of Crohn's disease: the case for an accelerated step-up treatment approach. World J Gastroenterol. 2008;14:2670-2677.
45. Hommes D, Baert F, van Assche G, et al. Management of recent onset Crohn's disease: a controlled, randomized trial comparing step-up and top-down therapy. Gastroenterology. 2005;129:370.